Fact CheckerSign in

NCT02087592Completed

Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Prospective Randomized Multicenter Trial to Assess the Feasibility of a Structured Physical Exercise Training and Mediterranean-style Diet in Women With BRCA1/2 Mutations

Source: ClinicalTrials.gov · Last updated 16 Apr 2024

Brief summary (registry, in English)

BRCA1/2 mutation carriers have a considerably increased risk to develop breast and ovarian cancer during their lifetime. There is evidence from the literature that for sporadic breast cancer disease risk and the course of disease can be significantly influenced by physical activity, nutrition and weight. The hypothesis of this 3 year, prospective randomized multicenter feasibility trial is that a structured life-style intervention program with exercise training and mediterranean diet is feasible and improves the nutritional and fitness status as well as the weight, the quality of life and stress reacting capacity.

Status (registry)
Completed
Study type
Interventional
Enrollment
69 (actual)
First submitted
12 Mar 2014
Start date
Feb 2014
Primary completion date
Nov 2014
Lead sponsor
Technical University of Munich
NCT number
NCT02087592

What you commit to

  • Study type: Interventional
  • Participants enrolled: 69
  • From Feb 2014 to the primary completion date, Nov 2014
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • severe concomitant disease which prevents from participating in the group interventions

Other illness

  • metastatic tumor disease
  • clinically limiting cardiovascular or respiratory disease
  • food allergies which prevent from mediterranean diet

Age

  • life expectancy \<3 years

Other

  • significant orthopedic disability which prevents from participating in the exercise training
  • Karnofsky index \<60
  • VO2max \>150%
  • Maximal exercise capacity \< 50 W
  • vegan diet
  • body mass index \<15 kg/m2
  • pregnancy
  • insufficient knowledge of German language
  • insufficient compliance
  • active participation in other interventional trials
  • no informed consent

Who the study is looking for

  • women with proven pathogenic BRCA1/2 mutation

Age in the registry: 18 years to 69 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Cologne
Coordinator of this site? Confirm its status
CologneGermanyUnknown status
University of Schleswig-Holstein Campus Kiel
Coordinator of this site? Confirm its status
KielGermanyUnknown status
Technische Universitaet Muenchen
Coordinator of this site? Confirm its status
MunichGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.